Final amended report on the safety assessment of oxyquinoline and oxyquinoline sulfate as used in cosmetics

International Journal of Toxicology

Volumn 25, Issue SUPPL. 1, 2006, Pages 1-9

  Andersen, Alan ^a  

^a Cosmetic Ingredient Review ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL; 8 QUINOLINOL SULFATE; BIOCIDE; COSMETIC; HYDROGEN PEROXIDE;

ACUTE TOXICITY; ARTICLE; CARCINOGENICITY; CHEMICAL STRUCTURE; CHROMOSOME ABERRATION; CHRONIC TOXICITY; COSMETIC INDUSTRY; DNA BINDING; DROSOPHILA; EYE IRRITATION; GENOTOXICITY; HUMAN; LIGHT ABSORPTION; NONHUMAN; PATCH TEST; PHYSICAL CHEMISTRY; RISK ASSESSMENT; SALMONELLA TYPHIMURIUM; SKIN TOXICITY; TOXICOKINETICS; ANIMAL; CHEMISTRY; DRUG EFFECT; EXPOSURE; EYE; FEMALE; FISCHER 344 RAT; MALE; MICROBIOLOGICAL EXAMINATION; MOUSE; MUTAGEN TESTING; ONCOGENE RAS; RAT; SKIN; TOPICAL DRUG ADMINISTRATION; TOXICITY TESTING;

ANIMALIA; RODENTIA; SALMONELLA;

ADMINISTRATION, TOPICAL; ANIMALS; COSMETICS; DROSOPHILA; EYE; FEMALE; GENES, RAS; HUMANS; INHALATION EXPOSURE; MALE; MICE; MICROBIAL SENSITIVITY TESTS; MUTAGENICITY TESTS; OXYQUINOLINE; RATS; RATS, INBRED F344; SKIN; TOXICITY TESTS;

EID: 33747047012     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810600716570     Document Type: Article

References (59)

1. Allavena, A., A. Martelli, L. Robbiano, and G. Brambilla. 1992. Evaluation in a battery of in vivo assays of four in vitro genotoxins proved to be noncarcinogens in rodents. Teratogen. Carcinogen. Mutagen. 12:31-41.
2. Armstrong, M. J., C. L. Bean, and S. M. Galloway. 1992. A quantitative assessment of the cytotoxicity associated with chromosomal aberration detection in Chinese hamster ovary cells. Mutat. Res. 265:45-60.
3. Asakura, S., S. Sawada, T. Sugihara, H. Daimon, and F. Sagami. 1997. Quinoline-induced chromosome aberrations and sister chromatic exchanges in rat liver. Environ. Mol. Mutagen. 30:459-467.
4. Ashby, J. and D. Paton. 1995. Chemicals for evaluating the sensitivity and specificity of reduced/transgenic rodent cancer bioassay protocols. Mutat. Res. 331:27-38.
5. Ashby, J., R. Mohammed, P. A. Lefevre, and L. Bandara. 1989. Quinoline: Unscheduled DNA synthesis and mitogenesis data from the rat liver in vivo. Environ. Mol. Mutagen. 14:221-228.
6. Association of American Pesticide Control Officials, Inc. (AAPCO). 1966. Pesticide Chemicals Official Compendium. 602.
7. Bernstein, E., P. Pienta, and H. Gernshon. 1963. Acute toxicity studies on 8-quinolinos and some derivatives. Toxicol. Appl. Pharmacol. 5:599-604.
8. Boyland, E. 1987. Estimation of acceptable levels of tumor promoters. Br. J. Ind. Med. 44(6):422-423.
9. Boyland, E., F. J. Roe, and B. C. Mitchley. 1966. Test of certain constituents of spermicides for carcinogenicity. Br. J. Cancer 20(1):184-189.
10. Clayson, D. B. and E. H. Cooper. 1970. Cancer of the urinary tract. Adv. Cancer Res. 13:271-381.
11. 2
12. 2
13. Cosmetic, Toiletry, and Fragrance Association (CTFA). 2002. Current use of Oxyquinoline and Oxyquinoline Sulfate. Unpublished data submitted by CTFA. (1 page.)
14. Draize, J.H., G. Woodard, and H.O. Calvery. 1944. Methods for study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Exper. Therapent. 82:377-390.
15. Eastin, W.C., J.K. Haseman, J.F. Mahler, and J.R. Bucher. 1998. The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying carcinogens. Toxicol. Pathol. 26:461-473.
16. Elder, R.L., ed. 1992. Final Report on the Safety Assessment of Oxyquinolone and Oxyquinolone Sulfate. J. Am. Coll. Toxicol. 11(4):497-507.
17. Epler, J. L., W. Winton, T. Ho, F. W. Larimer, T. K. Rao, and A. A. Hardigree. 1977. Comparative mutagenesis of quinolines. Mutat. Res. 39(3-4):285-296.
18. European Commission (EC). 2002. Twenty-sixth Commission Directive 2002/34/EC of 15 April 2002 adapting to technical progress Annexes II, III, and VII to Council Directive 76/768/EEC. Brussels: EC.
19. Foureman, P., J.M. Mason, R. Valencia, and S. Simmering. 1994. Chemical mutagenesis testing in Drosophila. X. Results of 70 coded chemicals tested for the National Toxicology Program. Environ. Mol. Mutagen. 23:208-227.
20. Fukushima, S., Y. Ishihara, O. Nishio, T. Ogiso, T. Shirai, and N. Ito. 1981. Carcinogenicities of quinoline derivatives in F344 rats. Cancer Lett. 14(4):115-123.
21. Food and Drug Administration (FDA). 1984. Cosmetic product formulation and frequency of use data. FDA database. Washington, DC: FDA.
22. FDA. 2001. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
23. FDA. 2002. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
24. Geelen, J.L., R.P. Minnaar, R. Boom, J. van der Noordaa, and J. Goudsmit. 1988. Heat-shock induction of the human immunodeficiency virus long terminal repeat. J. Gen. Virol. 69(4):2913-2918.
25. Gocke, E., M.T. King, K. Eckhardt, and D. Wild. 1981. Mutagenicity of cosmetic ingredients licensed by the European Communities. Mutat. Res. 90(2):91-109.
26. Grasselli, J.G., ed. 1975. Atlas of Spectra Data and Physical Constants for Organic Compounds. Cleveland: CRC Press.
27. Greenberg, L.A. and D. Lester. 1954. Handbook of Cosmetic Materials, 152. New York: Interscience Publishers Inc.
28. Hollstein, M., R. Talcott, and E. Wei. 1978. Quinoline: Conversion to a mutagen by human and rodent liver. J. Natl. Cancer Inst. 60(2):405-410.
29. International Agency for Research on Cancer (IARC). 1987. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 1-42, Suppl. 7, 56-74. Lyon, IARC.
30. Kabara, J. J. ed.. 1984. Cosmetic and Drug Preservation Principles and Practice, 618, 725. New York: Marcel Dekker.
31. Kiwada, H., M. Hayashi, T. Fuwa, S. Awazu, and M. Hanano. 1977. Pharmacokinetic study on the fate of 8-hydroxyquinone in the rat. Chem. Farm. Bull. 25(7):1566-1573.
32. Kubinski, H., G. E. Gutzke, and Z. O. Kubinski. 1981. DNA cell-binding assay for suspected carcinogens and mutagens. Mutat. Res. 89:95-136.
33. 2
34. 2
35. 2
36. 2
37. Liu, D., R. J. Maguire, G. J. Pacepavicius, and J. Carey. 1994. Microbial toxicity mechanism of copper-8-quinolinoate. Environ. Toxicol. Water Qual. 9:95-101.
38. Marchon, B., L. Bokobza, and G. Cote. 1986. Vibrational study of 8-quinolinol (Kelex 100), two representative members of an important chelating family. Spectrochim. Acta. A Mol. Spectrosc. 42(4):537-542.
39. McGregor, D. B., A. Brown, P. Cattanach, L. Edwards, D. McBride, and W.J. Caspary. 1988. Responses of the L5178Y tk+/tk mouse lymphoma cell forward mutation assay II: 18 coded chemicals. Environ. Mol. Mutagen. 11(1):91-118.
40. Ministry of Health, Labor and Welfare (MHLW). 2001a. Unofficial translation of MHW Ordinance No. 331, Attached Table 1 [Negative List]. Ministry of Health Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2,1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
41. MHLW. 2001b. Unofficial translation of MHW Ordinance No. 331, Attached Table 2 [Restricted List]. Ministry of Health Labor andWelfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2,1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
42. MHLW. 2001c. Unofficial translation of MHW Ordinance No. 331, Attached Table 3 [Preservatives] Ministry of Health Labor and Welfare, Pharmaceutical and Medical Safety Bureau, Inspection and Guidance Division, 2-2,1-chome, Kasumigaseki, Chiyoda-ku, Tokyo 100-8045, Japan.
43. Miyagawa, M., H. Takasawa, A. Sugiyama, Y. Inoue, et al. 1995. The in vivo-in vitro replicative DNA synthesis (RDS) test with hepatocytes prepared from male B6C3F1 mice as an early prediction assay for putative nongenotoxic (Ames-negative) mouse hepatocarcinogenesis. Mutat Res. 343:157-183.
44. Nagao, M., T. Yahagi, Y. Seino, T. Sugimura, and N. Ito. 1977. Mutagenicites of quinoline and its derivatives. Mutat. Res. 42(3):335-342.
45. 1 mice (feed studies). NTIS.
46. NCCLS. 1999. Methods for determining bactericidal activity of antimicrobial agents; Approved guideline. NCCLS document M26-A [ISBN 1-56238-384-1]. NCCLS: Wayne, PA. C-498.
47. Pepe, R. C., J. A. Wenninger, and G. N. McEwen, Jr., eds 2002. International Cosmetic Ingredient Dictionary and Handbook, 9th ed., Vol. 2, 947, Vol. 3, 2800. Washington, DC: CTFA.
48. Sax, N. I. 1979. Dangerous Properties of Industrial Materials, 5th ed., 952. New York: Van Nostrand Reinhold.
49. Shelby, M.D., G.L. Erexson, G.J. Hook, and R.R. Tice. 1993. Evaluation of a three-exposure mouse bone marrow micronucleus protocol: Results with 49 chemicals. Environ. Mol. Mutagen. 21:160-179.
50. Shelby, M. D., and K. L. Witt. 1995. Comparison of results from mouse and bone marrow chromosome aberration and micronucleus tests. Environ. Mol. Mutagen. 25:302-13.
51. Sideropolous, A. S., and S. M. Specht. 1984. Evaluation of microbial testing methods for the mutagenicity of quinoline and its derivatives. Curr. Microbiol. 11(2):59-65.
52. Talcott, R., M. Hollstein, and E. Wei. 1976. Mutagenicity of 8-hydroxyquinoline and related compounds in the Salmonella typhimirium bioassay. Biochem. Pharmacol. 25(11):1323-1328.
53. 2
54. Weast, R. C. 1982. CRC Handbook of Chemistry and Physics, 63rd ed., Boca Raton, FL: CRC Press.
55. Wilkinson, J. B. and R. J. Moore. 1982. Table 36.3. Some preservatives used in cosmetics and toilet preparations. In Harry's cosmeticology 7th ed., 687. New York: Chemical Publishing.
56. Williams, G. M. and R. S. Yamamoto. 1972. Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline induced siderosis. J. Natl. Cancer Inst. 49:685-692.
57. Windholz, M. 1983. The Merck Index, 10th ed., 706. Rahway, NJ: Merck and Co.
58. Yamamoto, S., K. Urano, H. Koizumi, S. Wakana, et al. 1998. Validation of transgenic mice carrying the human prototype c-HA-ras gene as a bioassay model for rapid carcinogenicity testing. Environ. Health Perspect. 106(Suppl. 1):57-69.
59. Yamamoto, R. S., G.M. Williams, H.H. Frankel, and J.H. Weisberger. 1971. 8-Hydroxyquinoline: Chronic toxicity and inhibitory effect on the carcinogenicity of N-2-fluorenylacetamide. Toxicol. Appl. Pharmacol. 19(4):687-698.